Case files
Disproven Suppression Claims
Some treatments have dramatic suppression stories but do not survive clinical evidence. This page documents those cases without dismissing the historical emotions around them.
A disproven claim can still have a real history. Regulators may have acted harshly, institutions may have been arrogant, and patients may have been searching for hope in a frightening situation. None of that proves clinical benefit. The cases below are included because the advertised medical claims outrun the evidence.
Disproven
Laetrile: the classic suppressed-cancer-cure story failed clinical evidence
Laetrile, also called amygdalin or incorrectly "vitamin B17," became one of the most famous cancer-suppression narratives in the United States. It had courtroom battles, state-level access fights, and a ready-made story about regulators blocking a natural cure. The National Cancer Institute's health-professional summary is direct: laetrile showed little anticancer activity in animal studies and no anticancer activity in human clinical trials.
The safety issue is equally important. NCI describes side effects consistent with cyanide poisoning, including liver damage, nerve-related walking difficulty, fever, coma, and death, and records that laetrile is not approved in the United States. A claim like this should not be revived by arguing that opposition alone proves efficacy. The relevant clinical question was tested and did not support the cure claim.
Disproven
Hoxsey therapy: historically important, but unsupported as cancer treatment
Hoxsey is complicated because the story has genuine historical texture: prosecutions, clinic closures, patient testimonials, and a long-running claim that organized medicine targeted a competing cancer treatment. This site links to hoxseyformula.com for a deeper archive of the Hoxsey history. But the evidence status here is separate from the narrative appeal.
Memorial Sloan Kettering summarizes the healthcare-professional record: Hoxsey Herbal Therapy is promoted as a cancer cure, is illegal in the United States, and has no clinical data supporting its value. MSK also notes that NCI evaluated case reports submitted by Hoxsey and found none showed efficacy. That does not mean every patient story was insincere. It means the treatment claim did not meet the burden required for cancer therapy.
Source: Memorial Sloan Kettering Hoxsey Herbal Therapy summary
Disproven
Gerson therapy: extreme regimen, weak evidence, real safety concerns
Gerson therapy is built around a strict diet, supplements, pancreatic enzymes, and repeated coffee or chamomile enemas. It is often marketed through detoxification language and patient survival stories. NCI's PDQ summary records the regimen and its rationale, but the evidence review does not establish it as an effective cancer treatment.
The safety record is not theoretical. The NCI/NCBI summary discusses case reports of adverse events associated with coffee enemas, including deaths attributed to electrolyte imbalance and infection concerns. A "natural" or dietary frame can make a regimen sound low risk, but intensive regimens can cause harm, especially when they delay conventional cancer care.
How disproven claims stay alive
Disproven claims often persist because the movement around the therapy changes the burden of proof. A trial failure becomes evidence that the trial was designed to fail. A regulator's warning becomes evidence of fear. A lack of reproducible cures becomes evidence that records were hidden. This is how the story protects itself from the evidence that should revise it.
The archive treats cancer cure claims with special caution because the cost of false hope is high. A patient can be harmed by toxicity, by financial exploitation, or by delaying therapy that has evidence for the specific cancer and stage. None of the entries on this page should be used as cancer treatment guidance.
Contrast cases
The existence of failed claims does not disprove every contested or once-rejected treatment. Compare these entries with H. pylori, artemisinin, and fecal microbiota therapy. In those cases, the evidence did not merely allege suppression; it changed the clinical record. When a claim depends on one paper, run that paper through the study scorer.